Johnson & Johnson
$129.209876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.9876543210-$,.
$129.20
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
9
8
7
6
5
4
3
2
1
0
-
$
,
.
+$1.18 (+0.92%) Today
$0.00 (0.00%) As of 5:50 PM EDT after-hours
Why Robinhood?
You can buy or sell JNJ and other stocks, options, ETFs, and crypto commission-free!
About JNJ
Johnson & Johnson is a holding company, which engages in the research and development, manufacture and sale of products in the health care field. It operates through the following segments: Consumer, Pharmaceutical, and Medical Devices. Read More The Consumer segment includes products used in the baby care, oral care, beauty, over-the-counter pharmaceutical, women's health, and wound care markets. The Pharmaceutical segment focuses on therapeutic areas such as immunology, infectious diseases ad vaccines, neuroscience, oncology, cardiovascular and metabolism, and pulmonary hypertension. The Medical Devices segment offers products used in the orthopedic, surgery, cardiovascular, diabetes care, and eye health fields. The company was founded by Robert Wood Johnson I, James Wood Johnson and Edward Mead Johnson Sr. in 1886 and is headquartered in New Brunswick, NJ.
CEO
Employees
135,100
Headquarters
New Brunswick, New Jersey
Founded
1887
Market Cap
337.87B
Price-Earnings Ratio
20.00
Dividend Yield
2.78
Average Volume
10.49M
High Today
$130.54
Low Today
$128.09
Open Price
$128.75
Volume
7.63M
52 Week High
$148.99
52 Week Low
$121.00
Collections
JNJ News
Reuters9h
Johnson & Johnson CEO testified Baby Powder was safe 13 days before FDA bombshell
LOS ANGELES/NEW YORK (Reuters) - Facing off against a plaintiff’s lawyer for the first time about Johnson & Johnson’s Baby Powder, the company’s Chief Executive
Analyst Ratings
56%
of 18 ratings
Buy
56%
Hold
39%
Sell
6%
JNJ Earnings
$1.95
$2.16
$2.37
$2.58
Q1 2018
Q2 2018
Q3 2018
Q4 2018
Q1 2019
Q2 2019
Q3 2019
Estimated
$2.00 per share
Actual
$2.12 per share
Popular Stocks
More JNJ News
BenzingaOct 19
Benzinga's Bulls And Bears Of The Week: Beyond Meat, Netflix, Johnson & Johnson And More
Benzinga has examined the prospects for many investor favorite stocks over the past week. Bullish calls included a second-tier telecom and a fast-casual restau
Washington PostOct 18
Johnson & Johnson recalls one lot of baby powder after trace amounts of asbestos found
The voluntary recall is limited to one lot of Johnson’s Baby Powder produced and shipped in the United States in 2018, the company said. Johnson & Johnson said
BloombergOct 18
J&J Recalls Lot of Baby Powder After Asbestos Trace Found
(Bloomberg) -- Johnson & Johnson is recalling one lot of its Johnson’s Baby Powder after tiny amounts of asbestos contamination were found in samples from a sin
ReutersOct 18
J&J recalls 33,000 bottles of baby powder as FDA finds asbestos in sample
(Reuters) - Johnson & Johnson (JNJ.N) said on Friday it is recalling around 33,000 bottles of baby powder in the United States after U.S. health regulators foun
MarketWatchOct 18
Dow ends lower pressured by Boeing, Johnson & Johnson, despite good earnings
Dow ends lower pressured by Boeing, Johnson & Johnson, despite good earnings More Dow sheds more than 250 points after data showed China’s economic growth slow
MarketWatchOct 18
The most generous country in the world and how much parents should worry about a Johnson & Johnson baby powder recall and arsenic in baby food
Happy Friday - and a happy weekend - MarketWatchers! Don’t miss these top stories: NBA analyst Stan Van Gundy on how the league has changed: ‘No one called the
